Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Erratum for Etienne et al., J Clin Oncol 10 (7) 1176-1182.

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Etienne, M.C.
Right arrow Articles by Namer, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Etienne, M.C.
Right arrow Articles by Namer, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 10, 1988, Copyright © 1992 by American Society of Clinical Oncology

ERRATUM

Pharmacokinetics and Pharmacodynamics of Medroxyprogesterone Acetate in Advanced Breast Cancer Patients

M.C. Etienne , G. Milano , M. Frenay , N. Renee , E. Francois , A. Thyss , M. Schneider , , M. Namer

There were several production errors in the report by Etienne et al, "Pharmacokinetics and Pharmacodynamics of Medroxyprogesterone Acetate in Advanced Breast Cancer Patients," published in the July 1992 issue (J Clin Oncol 10:1176–1182, 1992). In the abstract (p 1176), the abbreviation "Css minutes" should have been "Css min" for minimum steady-state concentration. The P value for the second footnote to Table 2 (p 1178) should have been ".99." In the Discussion section, the fourth sentence of the second paragraph (p 1180) should have read: "As concerns the 70 patients who received 1,000 mg/d orally, MPA concentrations ranged from 10 to 269 ng/mL (Fig 1)."


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1992 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online